Risperidone (Standard)
Risperidone (Standard) is the analytical standard of Risperidone. This product is intended for research and analytical applications. Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 98%
- No. CAS: 106266-06-2
- Fòrmula: C23H27FN4O2
- Peso molecular:410.48
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-11018
Risperidone5-HT2 Receptor Blocker -
HY-14541
Olanzapine5-HT2/D1/D2 Antagonist -
HY-10585
Valproic acidHDAC Inhibitor -
HY-14541R
Olanzapine (Standard)5-HT2/D1/D2 Antagonist -
HY-10585R
Valproic acid (Standard)HDAC Inhibitor -
HY-14543
Sertindole5-HT/DA Receptor Antagonist -
HY-50671
Zosuquidar trihydrochlorideP-gp Inhibitor -
HY-17367
AtazanavirHIV Protease Inhibitor -
HY-17390A
Loxapine succinateDopamine/5-HT Receptor Inhibitor -
HY-N1916
Coniferyl ferulateGST Inhibitor -
HY-135336
(R)-Verapamil hydrochlorideP-Glycoprotein Inhibitor -
HY-17407
Ziprasidone hydrochloride monohydrate5-HT/DA Receptor Antagonist
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 106266-06-2
-
Peso molecular 410.48
-
Fòrmula C23H27FN4O2
-
SMILES
O=C1C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)=C(C)N=C5N1CCCC5
-
Synonyms
R 64 766 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Nyberg S, et al. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl). 1993;110(3):265-72. [Content Brief]
[2]. Chen ML, et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils. Int Immunopharmacol. 2012 Jan;12(1):197-204. [Content Brief]
[3]. Zhu HJ, et al. Risperidone and paliperidone inhibit p-glycoprotein activity in vitro. Neuropsychopharmacology. 2007 Apr;32(4):757-64. [Content Brief]
[4]. Bardgett ME, et al. Adult rats treated with risperidone during development are hyperactive. Exp Clin Psychopharmacol. 2013 Jun;21(3):259-67. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Risperidone (Standard) Related Classifications
HY-11018R Related Classifications
Powered by Bioz